Abstract

Tumor-infiltrating lymphocytes (TILs) act as immune cells against cancer tissues. The manual assessment of TILs is usually erroneous, tedious, costly and subject to inter- and intraobserver variability. Machine learning approaches can solve these issues, but they require a large amount of labeled data for model training, which is expensive and not readily available. In this study, we present an efficient generative adversarial network, TilGAN, to generate high-quality synthetic pathology images followed by classification of TIL and non-TIL regions. Our proposed architecture is constructed with a generator network and a discriminator network. The novelty exists in the TilGAN architecture, loss functions, and evaluation techniques. Our TilGAN-generated images achieved a higher Inception score than the real images (2.90 vs. 2.32, respectively). They also achieved a lower kernel Inception distance (1.44) and a lower Fréchet Inception distance (0.312). It also passed the Turing test performed by experienced pathologists and clinicians. We further extended our evaluation studies and used almost one million synthetic data, generated by TilGAN, to train a classification model. Our proposed classification model achieved a 97.83% accuracy, a 97.37% F1-score, and a 97% area under the curve. Our extensive experiments and superior outcomes show the efficiency and effectiveness of our proposed TilGAN architecture. This architecture can also be used for other types of images for image synthesis.

Highlights

  • T UMOR infiltrating lymphocytes (TILs) play a significant role in cancer diagnosis and prognosis [1]

  • We present an efficient generative adversarial network, TilGAN, to generate high-quality synthetic pathology data of TIL and non-TIL regions to mitigate data imbalances, to improve the classification accuracy, and to assist pathologists and clinicians in their decisionmaking processes

  • OF TILGAN We evaluated the quality of our proposed TilGAN-generated fake images through a clinical evaluation by our experts

Read more

Summary

Introduction

T UMOR infiltrating lymphocytes (TILs) play a significant role in cancer diagnosis and prognosis [1]. The presence of TILs in different cancer types (such as lung, colon, and breast cancer) signifies improved clinical outcomes and faster response to chemotherapy [2]. Recent evidence has emerged that the infiltration of antitumor type I lymphocytes can improve cancer prognosis [3]. TILs are a special white blood cell that shows a tendency to emigrate towards tumor cells from the bloodstream [4]. TILs comprise mainly T cells, B cells, mononuclear cells, and polymorphonuclear immune cells (such as neutrophils, eosinophils, and basophils) [5].

Objectives
Methods
Results
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.